Hong Kong · Delayed Price · Currency is HKD Innovent Biologics Statistics
Total Valuation
HKG:1801 has a market cap or net worth of HKD 164.26 billion. The enterprise value is 143.85 billion.
| Market Cap | 164.26B |
| Enterprise Value | 143.85B |
Important Dates
The last earnings date was Tuesday, August 25, 2026.
| Earnings Date | Aug 25, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
HKG:1801 has 1.74 billion shares outstanding. The number of shares has increased by 7.87% in one year.
| Current Share Class | 1.74B |
| Shares Outstanding | 1.74B |
| Shares Change (YoY) | +7.87% |
| Shares Change (QoQ) | +0.75% |
| Owned by Insiders (%) | 6.55% |
| Owned by Institutions (%) | 53.48% |
| Float | 1.62B |
Valuation Ratios
The trailing PE ratio is 117.44 and the forward PE ratio is 45.18.
| PE Ratio | 117.44 |
| Forward PE | 45.18 |
| PS Ratio | 9.06 |
| PB Ratio | 6.86 |
| P/TBV Ratio | 7.38 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | 101.10 |
| EV / Sales | 7.93 |
| EV / EBITDA | 78.48 |
| EV / EBIT | 127.29 |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.68, with a Debt / Equity ratio of 0.11.
| Current Ratio | 2.68 |
| Quick Ratio | 2.35 |
| Debt / Equity | 0.11 |
| Debt / EBITDA | 1.36 |
| Debt / FCF | n/a |
| Interest Coverage | 18.46 |
Financial Efficiency
Return on equity (ROE) is 7.01% and return on invested capital (ROIC) is 28.31%.
| Return on Equity (ROE) | 7.01% |
| Return on Assets (ROA) | 2.10% |
| Return on Invested Capital (ROIC) | 28.31% |
| Return on Capital Employed (ROCE) | 3.39% |
| Weighted Average Cost of Capital (WACC) | 5.54% |
| Revenue Per Employee | 2.07M |
| Profits Per Employee | 162,526 |
| Employee Count | 8,754 |
| Asset Turnover | 0.48 |
| Inventory Turnover | 2.50 |
Taxes
In the past 12 months, HKG:1801 has paid 370.68 million in taxes.
| Income Tax | 370.68M |
| Effective Tax Rate | 20.67% |
Stock Price Statistics
The stock price has decreased by -6.49% in the last 52 weeks. The beta is 0.25, so HKG:1801's price volatility has been lower than the market average.
| Beta (5Y) | 0.25 |
| 52-Week Price Change | -6.49% |
| 50-Day Moving Average | 94.79 |
| 200-Day Moving Average | 86.88 |
| Relative Strength Index (RSI) | 41.56 |
| Average Volume (20 Days) | 14,048,178 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, HKG:1801 had revenue of HKD 18.13 billion and earned 1.42 billion in profits. Earnings per share was 0.80.
| Revenue | 18.13B |
| Gross Profit | 13.79B |
| Operating Income | 1.26B |
| Pretax Income | 1.79B |
| Net Income | 1.42B |
| EBITDA | 1.97B |
| EBIT | 1.26B |
| Earnings Per Share (EPS) | 0.80 |
Balance Sheet
The company has 23.09 billion in cash and 2.68 billion in debt, with a net cash position of 20.41 billion or 11.72 per share.
| Cash & Cash Equivalents | 23.09B |
| Total Debt | 2.68B |
| Net Cash | 20.41B |
| Net Cash Per Share | 11.72 |
| Equity (Book Value) | 23.95B |
| Book Value Per Share | 13.88 |
| Working Capital | 18.10B |
Cash Flow
| Operating Cash Flow | n/a |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 711.73M |
| Net Borrowing | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
Gross margin is 76.06%, with operating and profit margins of 6.97% and 7.85%.
| Gross Margin | 76.06% |
| Operating Margin | 6.97% |
| Pretax Margin | 9.89% |
| Profit Margin | 7.85% |
| EBITDA Margin | 10.84% |
| EBIT Margin | 6.97% |
| FCF Margin | n/a |
Dividends & Yields
HKG:1801 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -7.87% |
| Shareholder Yield | -7.87% |
| Earnings Yield | 0.87% |
| FCF Yield | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside |
Analyst Forecast
The average price target for HKG:1801 is 128.86, which is 36.58% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | 128.86 |
| Price Target Difference | 36.58% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 29 |
| Revenue Growth Forecast (3Y) | 27.30% |
| EPS Growth Forecast (3Y) | 41.89% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 4 |